Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Iron Metabolism New insights By Dr Mark Dawson Iron Significance Essential Element Key functional component of • O2 transportation & storage molecules (Hb, Mb) • Many redox enzymes (cytochromes) • Production of various metabolic intermediates • Host defence (NADPH oxidase) Iron Balance Strictly regulated Minimal loss 1 – 2mg/d Total body iron of 3 – 4g Erythropoietic iron requirement only 20mg/d Absorption is appropriately attenuated in dietary iron excess Important homeostatic mechanisms prevent excessive iron absorption in duodenum and regulate rate of iron release from RES Iron is toxic to human cells and essential for pathogens Control of Iron Metabolism Cellular Iron Homeostasis Concerned with each cells requirements for iron Systemic Iron Homeostasis Concerned with the body’s need for iron What we knew about iron Balance Intestinal iron absorption increases with Decreased iron stores Increased erythropoietic activity Anaemia Hypoxia Intestinal iron absorption decreases in inflammation Excess iron absorption relative to body iron stores is the hallmark of hereditary haemochromatosis Overview of Normal Iron Metabolism Iron Absorption (into enterocyte) Luminal surface – Dietary free iron (Fe3+) is reduced to Fe2+ – Occurs at brush border by duodenal ferric reductase (Dcytb) Transluminal transport – DMT1/Nramp2 (divalent metal transporter 1) – Dietary haeme iron via transporter and released from haeme or absorbed into the circulation. Understanding Heme Transport - N.C Andrews - New England Journal of Medicine:353;23 - 2508 Overview of Normal Iron Metabolism Iron Absorption (out of enterocyte) Shed Basolateral absorption via ferroportin or haeme transporter. Hephaestin facilitates enterocyte iron release Released by way of ferroportin into the circulation Ferroportin Present on the basolateral membrane of enterocytes Present on macrophages and other RES cells Present on hepatocytes Fleming, R. E. et al. N Engl J Med 2005;352:1741-1744 Overview of Normal Iron Metabolism Iron Tansport Via transferrin Iron Storage (Hepatic - major site) Hepatic uptake of transferrin bound Fe via classic transferrin receptor TfR1 (& homologous TfR2) Hepatocytes are storage reservoir for iron Taking up dietary iron from portal blood Releasing iron into the circulation via ferroportin in times of increased demand Iron Utilisation Erythropoiesis for haem synth / general cellular respiration via TfRs on erythroid precursors and other cells Generic Cellular Iron Uptake Generic Cellular Iron Uptake Generic Cellular Iron Regulation The IRE/IRP Regulatory System Each cell has the capacity to regulate its own utilisation of iron. This is co-ordinated via Iron regulatory proteins (IRP) and their binding to Iron regulatory elements (IRE) which are presents on nucleic acids. In this manner proteins involved in iron storage, erythroid haeme synthesis, the TCA cycle, iron export, and iron uptake are coordinately regulate. IRP act as the cell sensor to iron availability Who is in charge of all this Sites involved in iron homeostasis (absorption, recycling, storage & utilisation) are distant from each other Humoral regulation inflammatory / cytokine involvement in iron regulation Molecular basis of these signals was elusive for many years until a series of converging and serendipitous discoveries = Hepcidin Hepcidin 25 aa peptide. Identified 2000 Antimicrobial activity. Hepatic bacteriocidal protein Master iron regulatory hormone Factors regulating intestinal iron absorption also regulate the expression of hepcidin Decreased iron stores Increased erythropoietic activity Anaemia Hypoxia Iron Balance – General Comments Discovery of iron regulating hormone hepcidin provides cohesive theory to explain the pathophysiology of HH and ACD Cellular targets of hepcidin are villous enterocyte, RE macrophage and hepatocyte There are no substantial physiologic mechanisms that regulate iron loss Iron homeostasis is dependant on regulatory feedback between body iron needs and intestinal iron absorption Hepcidin Hepcidin Intestinal iron absorption varies inversely with liver hepcidin expression Hepcidin decrease the functional activity of ferroportin by directly binding to it and causing it to be internalised from the cell surface and deregulated • Decreases basolateral iron transfer and thus dietary iron absorption • Decrease in iron export by hepatocyte and macrophage and a resultant increase in stored iron Interplay of Key Proteins in Iron Homeostasis Hepcidin Response • TFR2 Transferrin receptor 2 may serve as a sensor of circulating transferrin-bound iron, thereby influencing expression of the iron regulatory hormone hepcidin • The hepcidin response is also modulated by HFE and hemojuvelin. • Inflammatory cytokines including IL-6 and LPS increase hepcidin secretion Interplay of Key Proteins in Iron Homeostasis Fleming, R. E. et al. N Engl J Med 2005;352:1741-1744 Disrupted Iron Homeostasis Hepcidin Deficiency: Hereditary Haemochromatosis: Absorb excessive iron relative to body stores implying the ‘set-point’ for the ‘stores regulator’ is altered. Ineffective erythropoiesis: Increased destruction of erythroid precursors (eg; thalassemia's) but this is coupled to increased iron absorption. Hepcidin Excess: Anaemia of Chronic disease: Infection/inflammation induce iron sequestration in macrophages and decrease intestinal absorption Haemochromatosis The field has expanded rapidly since the discovery of the HFE gene. The iron loading phenotype seen with mutations in the HFE gene are also seen in patients without mutations in this gene. The iron loading phenotype which is gradual in adults is seen in Africans with autosomal dominant inheritance. Children with severe iron overload disorders have also been identified Haemochromatosis It is very difficult to predict what the likelihood of clinical expression of the haemochromatosis phenotype. There are a number of host factors and environmental factors that influence the expression of the disease It is liklely that the disorder is more polygenic than originally thought. The major players • HFE: Normal HFE binds to B2M and associates with transferrin receptor 1. In patients with a HFE mutation (C282Y) a di-sulfide bond necessary for HFE & B2M interaction is disrupted leading to impaired expression of HFE. The original hypothesis was that HFE directly competed with Tfr1 and decreased iron absorption. Infact now we now HFE actually facilitates Tfr1 mediated iron absorption We also know that people with HFE have decreased levels of circulating hepcidin. HFE influence transcription of HAMP The crypt programming model and HFE-HAMP model of haemochromatosis The major players Transferrin receptor 2: Very little is known about its function. A homologue of Tfr1 Highly expressed in hepatocytes It is thought to be a sensor for iron stores and able to regulate HAMP gene Haemojuvelin: Highly expressed in hepatocytes Thought to also be a sensor for iron reserve and regulate HAMP (Hepcidin) Anaemia of Chronic Disease This is a very common disorder and thought to be also closely related to abnormalities in hepcidin. This is a syndrome of Hepcidin excess. The hallmark is the increased uptake and retention of iron within the RES Inflammatory mediators: Increase - DMT1, Ferritin, Hepcidin Decrease- Transferrin, Ferroportin Iron absorption from the GIT is decreased, iron availability for erythropoiesis is decreased, circulating transferrin with bound iron is decreased Weiss, G. et al. N Engl J Med Summary Much has been learned re regulation of iron homeostasis Many questions remain Molecular mechanisms how HFE, TFR2 & HJV influence hepcidin expression are unknown Additional gene products involved in iron metabolism have not been identified (eg: proteins participating in intracellular trafficking and how the systemic control of iron metabolism links to and influences the cellular control) Drug therapy - Hepcidin analogues and inhibitors